761 Exam 3

  1. What age group most commonly has HIV new dx
    • 25-29 
    • 20-24
    • 30-34
  2. what race has the highest HIV
    • blacks
    • hispanics
  3. Name some AIDs defining illnesses
    • Kaposi sarcoma
    • pneumocystitis jiroveci pneumonia
    • pulmonary tuberculosis
    • recurrent pneumonia
    • cadidiasis of bronchi, trachea or lungs
    • esophageal (not oral) candidiasis
    • invasive cervical cancer
    • Coccidioidomycosis, disseminated or extrapulmonary
    • Cryptococcosis, extrapulmonary
    • Cryptosporidiosis, chronic intestinal for longer than one month
    • Cytomegalovirus disease (other than liver, spleen or lymph nodes)
    • Encephalopathy (HIV-related)
    • Herpes simplex: chronic ulcer(s) (for more than one month); or bronchitis, pneumonitis, or esophagitis
    • Histoplasmosis, disseminated or extrapulmonary
    • Isosporiasis, chronic intestinal (for more than one month)
    • Kaposi sarcoma
    • Lymphoma Burkitt's, immunoblastic or primary brain (but not leukemia)
    • Mycobacterium avium complex
    • Mycobacterium, other species, disseminated or extrapulmonary
    • Pneumocystis jiroveci pneumonia (formerly Pneumocystis carinii)
    • Pneumonia (recurrent)Progressive multifocal leukoencephalopathy
    • Salmonella septicemia (recurrent)
    • Toxoplasmosis of the brain
    • Tuberculosis
    • Wasting syndrome due to HIV
  4. types of fever of unknown orgin
    • classic: fever over 38.3 on several occasions for more than 3 weeks. Dx uncertain after 3 days despite inpatient workup or 3 outpatient workups
    • nosocomial: fever over 38.3 on several occasions, pt hospitaliexed >24 hours but no fever present or developing on admission, eval of 3 days at least without finding cause
    • immune-deficient/neutropenic: fever 38.3 or more, neutrophils <500 per mm3, 3 days eval without cause found
    • HIV associated: recent fevers over 4 week period in outpatient or 2 days hospitalized with confirmed HIV. Dx uncertain after 3 days appropriate investigation (cbc, liver, ua, cxr, blood cultures)
  5. vaccines recommended for HIV adults
    • both pneumococcal conjugate (PCV13) and 23-valent pneumococcal polsaccharide vaccine (PPSV23)
    • hep A
    • hep B 3 dose primary series
    • yearly flu inactive
    • tdap/td q10
  6. pneumonia vax does for HIV
    • both pcv13 and PPSV23
    • PCV13: 1 dose for 19-64, 1 dose over 65 if no previous vaccination
    • PPSV23: 2 doses for 19-64 (1st at least 8 weeks after PCV13, second at least 5 weeks after first dose PPSV), For those 65 and up they should get 1 dose at least 8 weeks after PCV13 and then another dose at least 5 years after any PPSV23 that was given under 65
  7. HIV pap recommendations
    • pap at time of dx, 
    • another 6-12 months after
    • if normal, than paps annually, 
    • if 3 in a row, normal then q3 years
  8. HIV cotesting women over 30
    • if over 30 and positive, you can do cotesting (pap and hpv)
    • if they get a negative cotest they can have their next cervical cancer screening in 3 years
  9. why should all HIV ppl see a dentist
    • mouth lesions very common
    • fungal, viral, bacterial infections
  10. eye problems with HIV
    • CMV retinitis
    • cd4 count <100 is highest risk patients
    • do fundoscopic exam if advanced HIV
  11. FUO HIV labs
    • blood culture
    • cd4 count
    • chem7/cmp
    • hiv load
    • u/a and uc
    • hepatitis panel
    • cxr (if never done before)- not needed if sx havent changed since last

    • if abd symptoms
    • ct abdomen, liver test, stool studies
  12. most common AIDS related malignancies and presentation
    • systemic non-hodgkin lymphoma: fever, sweats, weight loss, lymphadenopathy, hepatosplenomegaly
    • primary central nervous system lymphoma: confusion, lethargy, memory loss, hemiparesis, aphagia, seizures
    • primary effusion (body cavity) lymphomas: pleural, peritoneal, pericardial or joint effusions with highgrade malignant lymphocytes
    • kaposi sarcoma: skin lesions on lower extremities, face, and genitals (can also be in mouth, gi tract or resp tract)
  13. AST and ALT
    • serum aminotransferases
    • usually elevated in liver diseae and in other diseases involving the liver like heart failure, infections, and malignancies
    • ALT more specific to liver disease
    • AST can be associated to other tissue like RBCs, muscle and kidneys
    • meds can raise these
  14. alk phosphatase
    • elevated in biliary obstruction, cholestasis, infiltrative liver diseases (ie tuberculosis), alcoholic steatonecrosis, cirrhosis and CF
    • also may be elevated in bone disorders, pregnancy or from meds
    • in HIV: can be elevated by CMV, MAC, microsporidosis and TB
  15. why is it important to assess pt compliance before starting HIV meds
    can develop reistance
  16. classess of antiretroviral meds (classic)
    • NRTIs: nucleoside/neucleotide reverse transcriptase inhibitors. abacavir, zidovudine, lamivudine, stavudine, didanosine, emtricitabine, tenofovir. 
    • NNRTIs: Nonnucleoside reverse transcriptase inhibitors. efavirenz, nevirapine
    • Protease inhibitors: Aprenavir/fosamprenavir, atazanavir, lopinavir, indinavir, nelfinavir, ritonavir, tipranavir, saquinavir
  17. new antiretroviral therapy classes
    • entry or fusion inhibitors: enfuvirtide
    • integrase inhibitors: end in "gravir"
    • chemokine coreceptor (CCR5) antagonist: maraviroc
  18. adverse effects of NRTIs
    • lactic acidosis
    • hepatic stenosis
    • body fat redristibution with wasting in face, arms and legs, accumulates in upper back
  19. adverse effects of NNRTIs
    • rash
    • steven johnson syndrome
    • toxic epidermal necrolysis
    • interact with many other drugs
  20. adverse effects of protease inhibitors
    • metabolic abnormalities: dislipidemia, hyperglycemia, insulin resistence, lipodstrophy
    • increased bleeding risk in hemophiliacs
    • interactions with other drugs
  21. baseline labs/tests before starting ART for HIV
    • fasting blood glucose
    • lipid panel
    • genotyping
    • rpr
    • trichomoniasis if female
    • toxoplasma gondii IgG (will need bactrim if cd4 <100)
    • hep panel
    • mammogram and pap
  22. strongest predictor of HIV disease progression
    CD4 count

    viral load used to lookong at response to therapy
  23. how long of ART does it take to decrease viral load below detection
    • 16-24 weeks
    • check q3-6 mo
  24. pneumonia commonness with cd4 count. which one is it most likely
    • cd4 > 200: strep pneumo
    • cd4 50-200: pneumocystitis pneumonia
    • cd4 < 50: mycobacterium ayium complext pneumonia
  25. Exudative pleural effusions and conditions associated
    • total protein fluid to serum ratio > 0.5 and LDH fluid to serum ratio greater than 0.6
    • serum effusion albumin of 1.2 or less
    • malignancy
    • bacterial infection
    • TB
    • connective tissue disease
    • PE/infarction
    • trauma
    • radiation
    • drugs/injuries
  26. transudative effusions and conditions associated
    • total protein fluid to serum ratio less than 0.5
    • total LDH fluid to serum ratio less than 0.6
    • serum effusion albumin over 1.2
    • chf
    • cirrhosis
    • nephrotic syndrome
    • profound hypothyroid myxedema
    • constrictive pericarditis
  27. best initial TB treatment strategy
    • a four drug regimen that includes always isoniazid and rifampin
    • the other 2 could be pyrazinamide and ethambutol to cover other areas if culture not done and its resistant
    • length of treatment depends on clinical presentation, HIV status and the acid fast status of the sputum at 2 months
  28. lupus labs
    • anti-neuclear antibody ANA: 95-98% will be positive, also seen in sjogren and scleroderma
    • anti-ds DNA antibodies: highly specific for SLE when moderate to high titre
    • c3 and c4: lupus tests, not highly specific, but sensitive
    • anti-cyclic citrulinated peptide antibody (anti-CCP): excludes Rheumatoid arthritis
    • CBC: look for hematological involvement- leukopenia, lymphopenia, anemia, thrombocytpenia, cooombs positive hemolytic anemia often is SLE
    • ESR: r/o rheumatoid arthritis, but also elevated in SLE 
    • rheumatoid factor: to rule out rheumatoid arthritis
    • cr/urinalysis: look for renal involvement- proteinuria, rbcs and rbc casts show glomerular disease which is common in SLE. also decreased GFR and elevated cr can be seen in SLE
    • fasting lipids: if sle, they have much higher CVD risk
    • glucose: prednisone can alter
  29. lupus rashes
    • molar "butterfly" rash
    • livedo reticularis- mottling rash from inflammed blood vessels
  30. SLE initial treatment
    • hydroxychloroquine for arthritis and rash, reduces flare ups
    • corticosteroids- prednisone 7.5
    • high spf sunblock for photosensitive rash
    • nsaids for msk pain, fever, headaches
  31. Most common age and race and category of new HIV diagnosis
    • 20-45 years old
    • black or hispanic
    • male to male sexual contact (after blood transfusion)
  32. top states with HIV
    • florida
    • california
    • texas
    • georgia
    • new york
  33. who should we test for HIV
    • EVERYONE aged 13-64 at least once regardless of risk
    • all pregnant women at every pregnancy
    • those with risk
  34. how often should we test for HIV
    • if no risk factors- once
    • as needed depending on risk behavior
    • q3 months if risk factor snd not on prep/pep (q1mo if super high risk)
  35. what is the best test to test for HIV
    • 4th generation test
    • can detect within 2 week window period
    • use this one to verfiy a home or rapid test
  36. when will a 4th gen hiv test pick up the diseae
    • 2 weeks at the earliest
    • can differentiate type 1 vs 2
  37. 4th generation test process
    • first will be pos or neg for 1/2. if negative done
    • if positive, it will go into if the HIV1 antibodie or HIV2 antibiodies or both are positive, or none
    • if you get a positive, you know your diagnosis, if negative, then youll go into a viral load
  38. viral load test
    • can detect within 7-10 days 
    • peaks at 4 weeks then plateaus
    • not ordered for every patient because its expensive
  39. tests for HIV and timeline of infection that they can detect
    • RNA viral load: 7-10 days
    • 4th gen: 2 weeks
    • Antibody test: 4 weeks
  40. viral load detectable timeline
    • detectable at 7-10 days
    • peaks around 10-24 then plateaus but is still detectable
  41. Acute HIV (acronym)
    • FRAT
    • Fever
    • Rash: maculopapular
    • Adenopathy
    • Sore Throat


    • NO cough, rhinorrhea, etc. can have n/v diarrhea, arthralgia/myalgia. 
    • more resembles mono (dry) than cold/flu
  42. onset of and how long does acute HIV last? does everyone have symptoms?
    • lasts 1-3 weeks
    • onset 2-6 weeks after infection
    • 40-90% are symptomatic
  43. other non FRAT symptoms of actue HIV
    • N/V/D
    • headache
    • myalgia/arthralgia
    • weight loss
    • thrush, neurological symptoms
    • hepatosplenomegaly
    • mouth ulcers
  44. what symptoms are NOT seen in acute HIV
    cough, congestion, rhinoorhea

    NOT like a flu or cold

    its a dry ilness

    remember to consider the risk. is it likely they have HIV
  45. Acute HIV labs
    • HIV RNA will be high druing days 15-25
    • HIV p24 antigen peaks just after detection
    • HIV antibody rises after acute phase

    • detectble at 2 weeks antigen and RNA
    • Antibody better detected towards end or after acute
  46. 90 90 90 goal
    • goal is that....
    • 90% of ppl know HIV status
    • 90% are on ART
    • 90% of people are suppressed
  47. HIV Exam
    complete plus in mouth, nodes, genitalia, anus
  48. hiv labs
    • cd4
    • viral load
    • genotype to see if transmitted resistance. you can pass resistance to others with the virus
    • CBC
    • bmp
    • lfts
    • ua
    • lipids
    • a1c
    • preg test
    • all STIs
    • toxo
    • CMV
    • varicella
    • IGRa
    • GC/chlamydia 
    • hep A, B and C (vax for a and b if needed)
    • HLA-B5701- only needed if using abacavir
    • G6PD (bactrim and dapsone can cause hemolytic anemia so need to know if they have this) if african or mediterranean decent
  49. tests for HIV
    • cervical pap smear
    • anal pap smear
  50. HIV cervical pap smear guidelines
    • < 30y: no HPV cotest needed. get at basleline, 6mo, yearly then if 3 are normal q3 years
    • 30 or older: HPV cotest needed, baseline, 6mo, then if thats normal q 3years
    • at any age if HPV positive or if LSIL or higher: Colpo
    • no guideline on when to stop
  51. anal pap guidelines for HIV
    • annual anal pap if receptive anal intercourse or if history of cervical dysplasia or cervical high risk HPV (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)
    • start at age 40 for anyone who has anal receptive intercourse or anyone with a cervix who has CIN
    • start if HIV+ at 35
  52. who gets an annual anal pap smear
    • hiv + and 35 or older
    • hiv- and 40 or older
    • hiv+ and active cervical HRHPV
  53. should you wait for genotyping before starting HIV meds
    NO, start ART immediately
  54. HIV prophylaxis for opportunistic infection based on CD4
    • If CD4 < 200: Bactrim DS daily to prevent PJP pna
    • If CD4 < 100: Bactrim DS daily to prevent toxoplasmosis
    • If CD4 < 50: Azithromycin 1200mg weekly to prevent Mycrobacterium Avium Complex (MAC)
  55. HIV med adherence Monitoring goals
    aim for >95%, one missed dose per month
  56. monitoring plan new HIV dx
    • if new dx, start ART, check viral load in 1 mo (should be suppressed)
    • if doing well, then re check q 3mo for 1 year, q4mo for 1 year then q6mo if stable viral suppression
    • if on q6mo schedule CD4 >300 can go to q12 mo CD4s then if >500 can stop checking all together
  57. if on ART, what should the viral load decrease to in HIV
    • <200 after 1 mo
    • < 20 within 6mo after any med change
  58. what do you need to monitor if someone is on a protease inhibitor
    • yearly lipids
    • yearly a1c
  59. what do you need to monitor if someone is on tenofovir
    yearly UA
  60. HIV+ healthcare maintenance
    • annual GC/chlaymydia/syphilus in sexually active pts
    • annual TST or IGRA in pt at risk for TB
    • HCV screening once, retest more frequently if risk factors
    • DEXA in postmenopausal women and men 50 or older
    • annual lipids, a1c, ua
    • one time screening AAA with ultrasound in men 65-75 if ever smoked
  61. HIV comorbidities
    • STIs
    • Hep B and C
    • smoking
    • CVD risk double
    • elevated cancer risk
    • Neuruologic impairment
    • osteopenia and osteoporosis
  62. CVD and HIV
    • cvd risk is double in those with HIV, however no valid calculator shows HIV as a risk factor
    • HIV pts are underprescribed ASA
    • get lipids and look at ASVD risk, if not a smoker, you can add this to the tool to get a more accurate risk
  63. HIV monitoring labs
    • Viral load
    • CD4
    • BMP
    • LFTs
  64. healthcare maintenance in HIV ppl
    • annual GC/Chlamydia/Syphillus in sex active
    • annual TST/IRRA at pts at risk for infeciton with TB
    • repeat HCV screening PRN if risk factors
    • Lipids, A1C, U/A annually + 2-3 mo after med changes
    • one time AAA screening ultrasound men 65-75 who ever smoked
  65. can you do a TST in all HIV ppl
    no, not if CD4 below 200, might not get a reaction, do an IGRA
  66. vacccines for HIV
    • annual flu shot
    • PCV13- once, followed by 2 PPSV pneumovax
    • COVID fully and boost
    • hep a and b if non immune
    • tetanus q10
    • mmr/varicella ONLY if nonimmune and CD4 > 200 for 3 mo 
    • shingrix once if 50 or higher
    • hpv series for 9-26 yo
    • meningococcal 0 and 2 months old and booster q5 years
  67. hiv vaccine rec differences from gen pop
    • pneumovax (PPSV23): twice. 1 dose then another 5 years later
    • meningococcal: regular 0 and 2 mo then boost every 5 years
  68. AIDS defining cancers
    • cervical (women with CD4 <200)
    • kaposi sarcoma
    • nonhodgkins lymphoma
    • primary central nervous system lymphoma
  69. cancers higher in HIV in order of higher
    • anal
    • vaginal
    • hodgkins lymphoma
    • liver
    • lung
    • melanoma
    • oropharyngeal
    • leukemia
    • colon
    • renal
  70. neurologic impairement with hiv
    • HAND spectrum- HIV associated neurological disorder
    • no ARTS have been shown for better outcomes
  71. classes of HIV meds and use
    • entry inhibitors: not really used anymore, neeeds tropism to be only CCR5 dominant, not CXCR4 or mixed
    • Fusion inhibitors: 100% get injection site reactions, not used
    • Nuceloside/Nucleotide Reverse transcriptase inhibitors: commonly used
    • Non-nucleoside Reverse Transcriptase Inhibitors: commonly used
    • Integrase inhibitors: our main tool now, used all the time
    • Protease inhibitors: commonly used
    • Pharmacologic enhancers/boosters: used, but not part of a regimen. enhance a regimen
    • Post-attachment inhibitor or monoclonal antibody: newer, consider if they have a lot of resistance to most other classes
  72. first line regimen for HIV classes
    • an integrase Strand transfer inhibitor 
    • PLUS 2 nulceoside reverse transcriptase inhibitors

    OR

    (dovato) Dolutegravir-lamivudine: first 2 drug regiment. except for individuals with HIV RNA over 500,000 copies/mL, hep b, or who ART is to be started before getting their genotyping results (this is an integrase strand transfer inhibitor + 1 NRTI.)

    as long as not pregnant.
  73. HIV first line regimen drug names
    • biktarvy (one pill): bictegravir, tenofovir and alafenamide-emtricitabine: tenofovir and emitricitabine are the nrti backbone and biktarvi is the integrase inhibitor
    • dolutegravir-abacavir-lamivudine: if HLA-B*5701 negative. you need HLA testing for this one. abacavir and lamivudine are NRTI 
    • Dolutegravir PLUS tenofovir alafenamide or tenofovir DF PLUS emtricitabine or lamivudine
  74. what class is truvada
    • contains 2 NRTIs
    • emtricitabine and tenofovir
  75. entry inhibitors and names
    • maraviroc or MCV (selzetry)
    • ccr5 antagonists
    • bind the CCR5 receptor and change it to prevent HIV protein binding and prevent entry
    • not used, sucks bc binding sites change overtime and not everyone has the same binding site
  76. fusion inhibitors and names
    • enfuvirtide (ENF) and T-20 Fuzeon
    • Binds to the heptad region and prevents the folding of the protein and prevents fusion to the host cell
    • an injectable
    • sucks and rarely used- TONS of injection site reactions
  77. nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), most common ones
    • most common: emtricitabine (emtriva), lamivudine (epivir), tenofovir alafenamide (Vemlidy), tenofovir disoproxil fumarate (viread)
    • mimic human nucleotides and can be interchangably taken up by reverse transcriptase
    • they dont have a 3-hydroxyl group so more nucleotides cant be added after and they terminate the chain
    • a fake nucleotide/nucleoside
    • the backbone of HIV meds. Very effective, few side effects, safe
  78. non-nucleoside reverse transcriptase inhibitors (NNRTIs) and most common use
    • doravirine (Pifeltro), Efavirenz (Sustiva), Rilpivirine (Edurant)
    • these go in the middle of the reverse trascriptase and prevent it from sqeezing and clipping the newly made DNA so it cant go on to do further things
    • like NRTIS, very commonly used and safe
  79. Integrase inhibitors (INSTIs) and names
    • bictegravir (Biktarvy)
    • dolutegravir (Tivicau)
    • Elvitegravir (Vitekta)
    • "gravirs"
    • our main tool
    • stops the enzyme that helps the HIV integrate its DNA into the host DNA
  80. HIV protease inhibitors and names
    • darunavir (Prezista) most commonly used 
    • "navirs"
    • good for those with resistance to NRTIs and NNRTIs
    • sit in the middle of the protease and stops it from snipping. stops arrest and maturation of proteins. 
    • Prevents infection of new cells
  81. pharmacokinetic enhancers HIV and names
    • ritonavir and cobicistat
    • Boosters. help boost another drug once it gets into the cells
    • used to boost another HIV regimen- keeps more in the cells
    • inhibits hepatic metabolism to boost drug levels, watch for drug interactions. acts at p450
    • allow pts to take lower doses with same effect
  82. post-attachment inhibitors or monoclonal antibody HIV and name
    • ibalizumab-uiyk (Trogarzo)
    • blocks HIV infected cells from spreading the virus to others
    • IV drug
    • given to ppl with significant resistance to other HIV drugs
  83. what first line recomendation can you use for someone who hasnt had a genetic test yet for HIV
    dolutegravir-lamivudine. 

    can be used first line for those starting therapy for the first time
  84. HIV rapid start and drugs
    • if you dx them and want to start right away and not wait for genotype, you should use
    • Biktarvy (BIC/TAF/FTC): VERY likely to work
    • Symtuza 
    • Darunavir/cobicistat + tenofovir/emtricitabine
    • dolutegravir + tenofovir/emtricitabine
  85. do you have to take food with HIV meds
    sometimes, some need acidic gastric pH for effective absorption
  86. HIV drug class common interactions
    • Integrase inhibitors: mg, al, ca, zn, fe. electrolytes. check antacid use
    • Doltegravir: metformin. increases concentration. they can only take 500mg bid max of metformin
    • boosters: statins- myopathy. atrovastatin ok only at 20mg/day
    • boosters: fluticasone (Cushings) other steroids too
    • atazanavir, rilpivirine: PPIs. these need acidic ph for absorption. Use H2 blocker instead
  87. should HIV + preg be on treatment? kid?
    • yes
    • and child should be treated 4-6 weeks post delivery
  88. PEP
    • post exposure prophylaxis
    • for those without HIV that have been exposed
    • used for postcoital, work exposure, contact with open wound, IVDU
  89. most common route of exposure for workplace HIV exposure and risk of getting it
    • percutaneous (ie needle stick)
    • risk is 0.2-0.3%
  90. Approach to needlestick injury HIV
    • wash area with soap and water
    • avoid squeezing "milking"
    • refer immediately to health
    • Get HIV status of source (4th Gen)
    • dont delay PEP while waiting for results
  91. PEP preferred regimens
    • integrase inhibitor + NRTI combination
    • raltegravir 400BID + tenofovir disoproxil fumarate and emtricitabine (descovy) 300mg-daily

    OR

    dolutegravir 50mg DAILY + TENOFOVIR DISOPROXIL FUMARATE-EMTRICITABINE 300MG daily
  92. Occupational PEP timeline
    • ideally start 30-90 in after exposure
    • no longer than 72 hours after exposure
    • if >72 hours, less likely to be effective, refer to expert
    • take for 28 days
    • can d/c if source comes back negative
  93. PEP side effects
    • nausea
    • fatigue
    • headache
    • very few se
  94. BASELINE labs for occupational HIV exposure
    • preg
    • hep B
    • hep C (Retest in 6 mo too)
  95. labs after PEP
    • Repeat after 2 weeks initiation
    • CBC, Renal function, liver test

    • repeat HIV testing at 6 weeks and 4 months after exposure
    • if non 4th gen test used, 6 weeks, 12 wks and 24 weeks after exposure
  96. when should you consult an HIV expert
    • more than 72 hours since exposure
    • unknown source (ie sticked from a sharps container)
    • known/suspected ART drug resistance
    • preg/breastfeeding
    • serious comorbidity
    • toxiicty from PEP
    • coinfected with Hep B or C
  97. how to evaluate to use PEP or not for nonoccupational HIV exposure (IE sex or IVDU)
    • if a negligible risk for HIV: dont use
    • if substancial risk and 73 hours or more since exposure: dont use
    • if substantial risk and 72 hours or less since exposure: look at source. if source known HIV+, do PEP, if unknown, case by case determination. look at behaviors and risk
  98. what qualifies a substantial vs negligible risk of HIV in nonoccupational exposure
    • substantial: exposure of vagina, rectum, eye, or mucous membranes or cut with blood, semen, vag secretion, rectal secretion, breast milk or blood when source is known HIV positve
    • negligible: exposure of same areas, but with urine, nasal secretion, saliva, sweat or tears not contaminated with blood regardless of the known status of the source
  99. indications for PEP
    exposure to blood, genital secretions, or other body fluids in a known HIV+ person within 72 hours of exposure and substantial risk for transmission
  100. highest and lowest risks of HIV transmission
    • highest: receptive anal intercourse and needle sharing
    • lowest: biting, spitting, sex toys, oral intercourse
  101. nonoccupational PEP regiemn and length
    raltegravir 400bid + tenofovir DF-emtricitabine 300 dailly

    OR

    dolutegravir 50 daily + tenofovir DF-emtricitabine 300 daily

    for 28 days. same as occupational exposure
  102. labs to get after nonoccupational exposure to HIV
    • hiv serological testing (pt and source)
    • cbc
    • liver
    • kidney
    • STIs (pt and source)
    • hep b and C (pt and source)
    • preg
    • viral load and resistance testing (source if infected)
  103. should you wait when transitioning from PEP to PrEP?
    NO. transistion without a gap
  104. PrEP regimens
    Truvada (tenofovir DF + emtricitabine) 300-200mg daily

    OR

    descovy (TAF + emtricitabine) 25-200mg daily

    these are both NRTIs
  105. how does PrEP work
    • interrupts HIV replication, stops reverse transcriptase
    • when taken daily, concentration is enough to protect against infection if exposed
  106. indications for HIV PrEP
    • ivdu
    • multiple partners
    • inconsitent condom use
    • recent STI
    • sex work
    • hiv+ partner not suppresed
  107. if a patient is at risk but doesnt want PrEP, how often do you screen them for HIV
    EVERY 3 MONTHS
  108. baseline labs for PrEP
    • 4th gen HIV test (1 week prior to starting)
    • viral load (if exposed and it hasnt been 2 weeks)
    • BMP
    • Gon/chlamyd: men who have sex w men and sex workers swab throat, urine and rectum) urine alone isnt enough
    • syphilis
    • HEpatitis: both truvada and discovy treat Hep B too, so you want to make sure they dont stop this if they have it
    • preg
  109. contraindications to PrEP
    • HIV: if you suspect, get a viral load, they need a full regimen. 
    • GFR <60ml/min: for truvada
    • cant take daily or follow up routineline

    • use with caution osteoporosis or hx fragile fracture
    • hep B +- make sure they stay on the regimen and get their tx
  110. how long until PrEP works
    • 7 days in rectum, 20 days in vaginal and blood
    • daily use required
    • NOT ENOUGH to treat someone with actual HIV and can cause resistance, make sure they dont have it
    • return if exposed and >7 days off PrEP, may need PEP
  111. PrEP monitoring
    • 1 month adherence after starting and baseline labs
    • q3 mo: HIV test, preg
    • q6mo: STI tests, BMP for med sfety (can do STI q3 mo if high risk)
  112. what if you get HIV while on PrEP
    • Unlikely unless not taking consistently
    • get: HIV RNA level, CD4 count, genotype
    • refer to specialist and STOP PreP. they may have resistance
  113. stopping PrEP if they have HepB
    • could cause hepatitis flare since HBV dna levels can increase dramatically
    • keep them on it
  114. PrEP on demand
    • Before sex: 2 PrEP tablets at least 2 hours and ideally 24 hours before sex
    • After sex: 1 PrEP 24 hours after the 1st dose you took, and then another PrEP tablet 48 hours after the 1st dose you took (total 2 tabs after sex)
    • not FDA approved
  115. what metric does case control study give you
    odds ratio
  116. case control study
    known outcome, look retrospectively to see if they had the exposure
  117. bayes theorem and example
    • post-test probability depends on pre test probability
    • if you want to know the probability of developing lung cancer in a population, that risk is not evenly distributed- it depends if you smoke work in high risk environment etc bc those increase your pre-test probability
    • if your initial risk was 30% ands smoking increases risk by 3%, your new risk is 33%
    • pre test probability also affects positive and negative predictive values: if pre test probability is very low, even someone who gets a positive result has a good chance its a false positive, bc the pre test probability is low. alternatively if youre in an area with a high pre test probabiliyt, even if somone is negative,
  118. cohort study
    • can be prospective or retro
    • you choose the exposure, and see if they get the case
  119. sensitivity equation
    • true positives/(true positives+false negatives) 
    • aka true positives / everyone who really is positive
  120. specificity equation
    • true negatives / true negatives + false positives
    • aka true negatives / everyone who really is negative, regardless of what they tested
  121. when do you want a highly sensitive test
    • if a false negative or a positive test is dangerous
    • to confirm that someone does not have the disease
    • if its negative it rules out
  122. when do you want a highly specific test
    • for confirmation testing
    • if a false positive result is dangerous
  123. positive predictive value
    • the probability that a person who tests positive actually has the disease
    • true positives / all who tested positive
    • a form of post test probabily, depends on pre test probability
  124. negative predicitve value
    • the probability that someone who tests negative actually is negative
    • true negatives / all that tested negative
    • tells how reliable a test result is
    • a form of post test probability, depends on disease prevlance
  125. ruling in
    high POSITIVE predictive value with high sPecificicity
  126. ruling out
    high NEGATIVE predictive value and high seNsitivity
  127. liklihood ratio
    • measures how predictive a finding is for a disorder
    • tells you how much your post test probability changes based on the finding
    • independent of prevalance, once you know the ratio you can apply it to any population
    • if more than 1: increased probabily that the disorder is present
    • if 1: test result does not change the probabily of the disease at all
    • if less than 1: an decreased probbility that the targt disorder is present

    • lr >10 = high likelihood that disease is present
    • lr <0.1 = greatly decreased liklihood of disease presnce

    lr of 0.1 means the liklihood was decreased by 90%, where an LR of 10 means the likelihood increased 10x
  128. are Liklihood ratios negative ever
    no, their numbers are always positive, but it will be described as pos or neg depending on if the finding is present or absent
  129. example of liklihood ratio
    • if ddimer is positive, you have a positive liklihood ratio of DVT occurance
    • if ddimer is negative, you have a negative liklihood ratio for DVT occurance
  130. confidence interval
    • gives you a precision of the point estimate
    • a range of values
    • if the range crosses 1 it is NOT significant
  131. What are the 2 safety issues with botanicals that ARE addressed
    • adulteration: making sure the plants in things are good quality and not contaminated. ie where they are made. Chemical compounds, other botanicals, pharmaceutical drugs
    • contamination: heavy metals, pesticides, microbial contaminants

    these top 2 are addressed by good manufacturing practices (GMPS)
  132. What are some issues with botanicals that are NOT addressed by good manufacturing practices?
    • safety of the plant itself
    • herb interactions with other drugs or food
  133. are herbal products regulated?
    • yes! this is a myth that they arent
    • the regulation is somewhere between food and drugs- like vitamins
  134. what can herbal products be
    • dietary supplements
    • foods
    • topicls
    • some are active ingredients in  OTC product
  135. name an otc product that has herbs
    senna leaf
  136. what are the dietary supplement regulations
    • good manufacturing practices: all ingredients must be identified, batches mixed properly, good testing
    • claims must be true
    • must report adverse events to the FDA- you have to notify them, but no pre-market approval needed
  137. name some low risk herbs
    • chamomile 
    • lemon balm 
    • raspberry leaf
    • milk thistle (hepatic protective)
  138. name some middle risk herbs
    • senna leaf
    • licorice
    • coffee
    • comfrey
  139. high risk herbs
    • foxglove- digoxin tox
    • aconite
    • hellebore
  140. what is an adverse event and example with botanicals
    • abnormal sign, symptom or worsening of health
    • happens after taking a product
    • may or may not be related to the product

    ie if you had a cup of throat coat and your pinky toe hurt after- could be related, could not be
  141. what is an adverse effect and example with botanicals
    • an adverse event 
    • the relationship between the product and the event is at least plausible
    • ie you take senna and get bad cramping
  142. What is a side effect
    • any unintended effect of a product
    • occurs at the standard therapeutic dose
    • effects are related to the product
  143. what to consider when looking for a cause of an effect/event
    • temporal relationship
    • other diseases/drugs/supplements that could have caused
    • biological plausability
    • rechallenge results- they take it again see if it happens again
  144. assessment scale of if an adverse effect is from a med
    • certian
    • probable
    • likely
    • possible
    • unlikely
    • unassessable
  145. does coumarin cause bleeding
    • no, 
    • its related to coumadin but not the same. 
    • aromatic compound found in many herbs including tonka been, sweet woodruff, sweet grass
    • can be converted to dicoumarol which is warfarin by mold so watch out
  146. are herbs inherently safe
    • no
    • think of foxglove, livertoxins, etc
  147. do garlic, ginger, gingko cause bleeding
    no, very low risk
  148. when do you worry about an herb
    • more concentrated, like in a pill form
    • rather than just eating the food
  149. what is ginkgo used for
    • to help with memory
    • so old ppl take it, more falls may falsely look like more bleeding
  150. types of herb interactions
    • additive effects to a drug
    • opposing effects
  151. tumeric and black pepper
    often prescribed together bc they enhance each other
  152. what happens to a drug if cyp450 is induced
    means it metabolizes more so theres less drug in the body
  153. what happens to a drug if cytochrome p450 is inhibited
    cant metabolize as fast so there is more drug in the blood
  154. what drugs should you be careful with with herbs
    • ones metabolized by cyp450 
    • ones with narrow therapeutic window
  155. p-glycoprotein
    • a protein in cell membrane
    • transports drugs out of cells
    • when inhibited, more drug in the cell
    • when enhanced, more drugs pushed out of the cell
  156. herb safety classifications
    • 1: herbs that can be safely consumed whe used appropriately
    • 2: herbs wehre use restrictions apply unless otherwise directed. such as: a-external use only, b- not in preg or c- breastfeeding, or other specifics
    • 3: herbs with significant data to recommend label that says "use only under supervsion of qualified expert"
    • 4: herbs with insufficient data for classification
  157. interaction classifications of herbs
    • a: can be safely consumed with any prescription or non prescription drugs or other supplements
    • b: herbs for which clinically relevant interactions are biologically plausible
    • c: herbs for which clinically relevant interactions are known to occur
  158. kava
    • piper methylsticum
    • a muscle relaxant and eases stress
    • heavy long term use >6g/day causes scaley yellowing skin
    • myth that it causes liver tox
    • safety class 2b, 2c, 2d, interaction class B
  159. green tea
    • safety class 1, interaction class c (bc concentrated for weight loss)
    • liver toxicity when in ethanol extract
    • reduces risks liver disease
    • dont use with CNS stimulants, bronchodilaters, adrenergic drugs
  160. garlic
    • safety class 1 interaction class c
    • antiplatelet activity, but no increased bleeding risk with warfarin
    • safe at dietary levels, dont conentrat
    • dont use therapeutic doses with anticoag or antiplatelets
    • infants like it in breast milk
  161. does cranberry interact with warfarin
    no
  162. echinacea
    • purple coneflower 
    • safety class 2b, 2d, interaction class B
    • used for flu, sore 
    • myth that it has bad heart effects
  163. licorice
    • safety: 2b, 2d
    • interaction: b
    • no adverse effects at standard therapeutic dose with less than 5g daily for 6 weeks
    • excessive use depletes K, raises Na, high bp, tachycardia, temp loss of vision, temp paralsis
    • often happens from too much candy
  164. contraindications to licorice at therapeutic doses
    • preg
    • HTH, liver disese, water retention, kidney disease, low K, CF
  165. Black cohosh
    • for menopause
    • safety: 2b
    • interaction: A
    • good safety
    • similar species in china caused toxicity
  166. Ginko
    • for mental function, memory, anxiety
    • safety: 1 inteaction: b
    • no effect on bleeding
    • induced cyp
  167. st johns wort
    • for dep
    • safety: 2d
    • interaction: C
    • causes photosensitivity
    • induces p-gp and cyp
    • decreases many drug levels
  168. milk thistle
    • safety: 1
    • interaction: A
    • safe to use
    • can decrease fasting blood glucose
  169. what worse care do LGBTQ have
    • higher breast cancer in lesbians- nulliparity
    • less likely to have insurance
    • more likely to be homeless
    • higher cancers of gentials if they keep their original
    • Older LGBTQ adults have a higher prevalence of obesity, cardiovascular disease, arthritis, asthma, and depression.
    • Older LGBTQ adults with depressive symptoms have lower rates of access to healthcare services including preventative care services.
    • Higher prevalence of anal cancer among gay men than the general population. 
    • higher obesity lesbians
  170. LGBTQ suicide stats
    • 2-3 x likely to attempt
    • almost 2 x as likely to complete
  171. LGBTQ and substances
    this pop has the highest rates of alcohol, tobacco and drug use
  172. what age can consent to sexual care
    • 16
    • however, need parental consent for transgender therapy and meds
  173. when can you start puberty suppression
    • tanner stage 2-3
    • kids at 12-13
    • need parental consent
  174. tanner 2 girls
    breast bud development
  175. tanner 2 guys
    • enlargement of testes first
    • may be some pubic hair or penis growth
  176. what should you check before starting puberty blockers
    • have they had a behavioral health consult
    • hx of gender identiy incongruence and dysphoria
    • hx of gender affirming measures
    • Growth charts (these will suppress growth hormones- watch esp in kids on stimulants- weight loss)
    • look at pubertal development, make sure they are tanner 2-3
  177. do you need a chest/genital exam to start puberty blockers
    • yes
    • you can defer initially, but cant start the meds til you see
  178. baseline labs before starting puberty blockers
    • serum estradiol and/or testosterone depending on birth sex
    • LH
    • FSH
    • renal/liver function
    • consider bone age with Xray of Left hand if there are height concerns
    • vit d screening in pts with disrodered eating, low bmi, inactivity, poor calcium intake, bad diet
  179. what are puberty blockers
    • gonadotropin releasing hormone (gnRH) agonists
    • put the pause on pubety
    • activate GNRH receptors and cause decreased or suppressed gonadotropin secretion
    • suppress gonads from making estrogen, progesterone or testosterone
  180. What puberty blockers are used
    • leuprolide (lupron): IM q28 days. start at 7.5mg-11.25mg if under 25kg. 11/25-22.5 if over 25kg. most common
    • luprolide acetate: IM q12 weeks (3 mo). 11.25-22.5
    • histrelin acetate: sub q implant 50mg q12 mo
  181. can you adjust GnRh puberty blocker therapy and if so dose
    • yes- if elevated testosterone or estradiol, FSH/LH or clinical evidence that they are still going through puberty
    • watch out, this can initially worsen- flare expression of gonadotropin- can accelerate puberty before blocking effect takes action
    • if doing lupron q28: increase by 3.75mg q4 weeks til desired response
    • if leuprolide acetate q12 weeks: increase to 22.5mg or 20mg, and shorten time between injections
  182. when can spironolactone be used LGBTQ
    • to suppress testosterone in boys wanting to stop puberty or become girls
    • not enough to suppress testosterone alone, you also need GNRH
    • starting 25mg- 300 mg, day. can adjust by 20-50 mg intervals per day til desired effect (suppression of testosterone). watch BP and electrolytes (K)
  183. when should you follow up after starting GnRH puberty blockers? when should you ask about gender confirming?
    • 1 month after start
    • q3 mo after that
    • check growth, tanner stage to see if pub was blocked or continued
    • talk to them about affirming around 15-16. they cant stay on this forever they need to grow
  184. follow up labs/assessment 1 mo after starting puberty blockers GNRH
    • LH, FSH, total testosterone or estradiol, liver function: we check these to assess adequate suppression of hypothalamic-pituitary-gonadal axis 6-8 weeks after lupron q28 start or 8 weeks after 3 month dosing
    • repeat the lh, fsh, estradiol/testosterone, renal and liver function q3-4 mo
    • annual labs: a1c, lipids, glucose, insulin, alk phos, calcium, vit d
    • annual xray bone age: if concerned about height/weight
  185. when do you need an annual bone density scan if on puberty blockers
    if on GNRH agonists for more than 2 years
  186. what can you use for gender dysphoria if GNRH agonists are not an option for puberty blocking. (for each gender)
    • if female at birth: depo provera q12 weeks to suppres menses. IUDs too but they may not want invasive
    • if male at birth: spironolactone 25-300mg daily to suppress testosterone. watch bp and electrolytes
  187. if someone is on lupron, what should you tell them about diet/activity
    • lots of weight bearing excercise for their bones
    • diet adequeate in calcium and vit d
  188. when can you start gender affirming hromone therapy while on GNRH puberty blockers in youth
    • if age appropriate development of secondary sex characteristics
    • persistent, stable and well docd gender identity, 6+ months per dsm5
    • stable mental health and medical conditions
    • pubertal suppresion has allowed pt to integate their gender more fully and decide
  189. are there any medical contraindications to starting gender affirming hormone therapy
    no, not in general. specific meds might
  190. when should you start gender affirming hormone therapy if on GNRH puberty blocker
    • around age 16
    • start before 16 if: bone health worries, going through puberty in late adolescence/college
    • data shows that if they still have gender dysphoria at adolescence they are unlikely to want their birth sex
  191. testosterone therapy and formulations
    • used to induce male secondary sex characteristics: muscle mass, body/face hair, voice change, enlargement of clitoris
    • suppresses estrogen production- uncessary if on a GnRH agonist, thats already doing it
    • historically given IM, now SC better
    • topical ok for adults, not kids
  192. testosterone dosing and increases while on a GnRH puberty blocker
    • Subq: 12.5mg weekly x 8-12 weeks, then increase to 25mcg weekly
    •        check levels in 3 mo and adjust by 12.5mg weekly as needed. most reach desirable results and appropriate blood levels at 50-75 mg weekly
    • IM: 25mg IM weekly or biweekly x 8 weeks then increase to 50mg weekly. if dosing is biweekly, double dose
    •          most do well on 50-100 weekly or 100-200 biweekly. takes longer than sc to get into your system so higher dose needed
  193. follow up schedule for trans masculine (becoming men) patients
    • 3-6 mo: testosterone levels q3-6 mo until levels stable. goal testosterone 320-1000 ng/dL; hematocrite
    • 12 mo: serum testosterone, total testosterone, hematocrit, lipid profile
    • yearly: hematocrite, once stable serum T not needed anymore. lipids, glucose, a1c
  194. what needle should be given for subq testosterone
    • 18g 1in for drawing up
    • 25g 5/8 in for adminstration

    inject to thigh, flank switch sides every week
  195. should you inject testosterone into the belly
    • no
    • you can get lipodystrophy so belly not good for image. 
    • rotate injection sites!
    • induration of the area can happen, massage after injection
  196. needles for IM testosterone administration
    • 18g 1 inch for drawing up
    • 21-25g 1in needles for injection. mostly 23 or 25
    • inject into thigh, switch sides each time
  197. what do you need to think of with testosterone suspensions
    suspended in cottonseed oil, check allergies
  198. do you need a DEA to rx testosterone
    • yes, a controlled med
    • pt needs ID to pick up from pharmacy
  199. estrogen therapy and forms
    • 17b estradiol induces female sex characteristics: breasts, redistribution of fat, softening facial features
    • does not completely suppress testosterone function: so you can use a GnRH agonist to do this or another agent like spironolactone
    • oral, IM or transdermal
  200. Estrogen dosing while on a GnRH agonist
    • transdermal: 6.25ug patch twice weekly, increase dose q3-6 mo to adult dose of 200-400ug twice weekly. NOT RECOMMENDED ROUTE
    • oral/sublingual: 0.25mg daily, increase dose q3-6 mo until adult dose of 4-8mg daily
    • IM: estradiol valerate 5mg biweekly, increase q3-6mo until adult dose of 10-40mg biweekly OR parental IM estradiol cypionate 2mg/week increase q3-6mo to adult dose 10mg weekly
  201. are estradiol valerate and parental im estradiol cypionate interchangable
    yes, but dosing is different!
  202. follow up labs for transfeminine (on estragen therapy ) pts
    • 4-6 weeks: if on spironolactone- check K, BUN, cr, then check these 4-6 weeks after any dosing changes of this
    • 6 months: estradiol level goal 100-200pg/mL, total testosterone should be 50-50 ng/Dl (normal female range). Potassium, BUN, cr
    • annually after stable dose and goal concentration met: serum K, bun/cr, estradiol, total testosterone, prolactin (more often if sx of hyperprolactinemia or pituitary adenoma), lipids, glucose, a1c
  203. estrogen considerations
    • VTE risk
    • worry if tobacco use or hx VTE 

    if a smoker AND hx VTE: CONTRAINDICATED. 1 or other is okay in youth. not adulthood
  204. do women on estrogen need aspirin to prevent VTE? do they need to stop estrogen before surgery?
    no and no
  205. IM estrogen needles and injection site
    same as testosterone
  206. what estrogen route is best for breast development
    slow delivery- transtermal
  207. when do you stop GnRH agonists (puberty blockers)
    • no consensus when to stop if they have started affirming therapy
    • you can continue into early adulthood, may help
    • if they are on GnRH alone WITHOUT affirming therapy, at 2-3 years talk to them about time to make a decision. or around 16. earlier if bone risks, etc
  208. whats the difference in dosing gender affirming hormone therapy when NOT on GnRH agonists (puberty suppressants)
    • same initial dosing
    • may need to increase initial doses and increase dosing more frequently bc the pt has already gone through sex of origin puberty
  209. do you need consent of both parents for gender affirmation therapy or puberty blocking
    not in MA- 1 parent ok, but try to get both bc this can be used against parent in custody battles
  210. Gender affirming therapy doses adults
    similar to kids
  211. is gender dysphoria and gender identity disorder a psych diagnosis
    • yes 
    • in DSM5
    • dont code for this, can create stigma
  212. why might someone getting estrogen on the street and wanting to be transfemale have lumps in fatty areas
    • fat deposits from injection of street collagen
    • can get infected or ulcer or silicon embolization
  213. femininizing therapy in adults
    • estrogens
    • antiandrogens
    • prgestagens- improve breast development, mood, libido
  214. antiandrogens for feminizing therapy
    • spironolactone 200-400mg daily. caution with kidney problems
    • 5-apha reductase inhibitors (finasteride and dutasteride). good choice if cant tolerate spironolactone
  215. masculinizing therapy for adults
    • testosterone
    • thats it
  216. will testosterone tx in transmasculine prevent pregnancy
    no, but it can cause ammenorhea
  217. What is the only ABSOLUTE contraindication to gender affirming hormone treatment
    active sex hormone receptive cancer
  218. what referrals might a trans patient need
    • dermatology: hair removal, silicone injections, cosmetic procedures, acne
    • endocrine: bone issues, DM, complex hormone therapy
    • ID: HIV or other STI
    • reproductive endocrinology: fertility
    • plastics: gender affirming procedures
    • behavioral health
  219. breast cancer screening guidelines in LGBTQ - who, when, what
    • if they have breasts do it- so trans women and trans men that have not had mastectomy
    • start screening after 5 years of starting femininzing therapy, regardless of age
    • transgender women over 50: screen 5-10 years after starting hormone therapy start
    • mammogram q 2 years
  220. LGBTQ cervical cancer screening
    • not a requirement to start testosterone
    • same screening as cis women
    • start at 21 regardless of sex activity or homones
    • higher liklihood of unsatisfactory result while on testosterone
  221. LGBTQ cervical cancer prep in a trans male
    • lots of lube
    • 1 week vaginal estrogen before exam
    • have them get a ride and give a benzo
  222. active tb vs latent
    • active: mycobacterial infection spread via droplets. can affect lungs or body. Fever, weight loss, night sweats, fatigue, LAD, cough, hemoptysis, CP. can spread. positive CXR and smear/culture
    • latent: m. tuberculosis infection but no active disease. no sx, not contageous, but positive TST/IGRA, neg CXR or sputum cult/smear
  223. how many untreated latent TB will become active and when? what if they have HIV
    • 10%
    • most likely 1-2 years after exposure
    • if HIV: 10% PER YEAR
  224. Latent tb screening / care cascade
    • identify high risk
    • screen them
    • if positive test, CXR and symptom screen
    • if negative sx and CXR start Latent TB treatment
    • folow up monthly and complete full therapy regimen
  225. who do we screen for TB
    • Everyone who is asymptomatic, over 18 and at increased risk, meaning
    • born to an endemic country and lived there over 1 mo, regardless of when they came here
    • immunosuppressed (hiv, organ transplant, biologic use)
    • close contact to active infection
    • IVDU, homeless, prison, healthcare worker
  226. what countries should you screen for TB
    anything other than US, puerto rico, canada, australia, new zealand or weast north europe
  227. Tuberculin skin test what is it
    • intradurmal purified protein
    • read after 48-72 hr
    • rxn measured in mm
  228. TST and BCG vaccine
    • common myth that BCG gives positive skin test. if they got it in infancy and its been 10+ years, very unlikley
    • however if they got it after 1 year old, and even if its been 10+ years, can have pos result
  229. interferon gamma release assays. types and what are they
    • types: quantiferon Tb gold, and T-spot
    • looks at how your immune system responds to the antigen. in the blood not skin
    • draw blood and put in a tube with the antigen and look for cd4 cell response. if + your body has seen the antigen before
    • 8-30 hours to get results
  230. does tst or IGRA have better sensitivity and specificity
    • both highly sensitive, tst a little more
    • igra highly specific, very few false positive
  231. pros and cons of igra test
    • pros: single visit, results in 24 hours, prior bcg vaccine ok
    • cons: limited data in kids under 2, expensive, samples must be processed in 8-30 hours
  232. TST PPD positive indurations by group
    • 15mm or more: positive for anyone over 4
    • 10mm or more: ppl with conditions that increase risk of reactivation (HD, silicosis, malignancy, DM, malnutrition, jejunal bypass, IVDU), residents/emp in high risk settings (hospital, jail, homeless, labs), kids under 4, and foreign born or immigrated from endemic country
    • 5mm or more: HIV+ (regardless of CD4), close contact with active case, abnormal CXR with fibrotic changes, immunosuppressed
  233. what can cause a false ppd but not IGRA
    • bcg vaccine
    • another non tb mycobacterium- bcg vaccine is made from another myco
  234. when can ppd have a false negative
    • immunosuppressed: HIV, steroids, cancer, tnf alpha, malnourished, ckd
    • active TB
    • recent TB
    • recent live vaccine MMR
    • improper test technique or protein
  235. what if someone has a recent tb exposure, should you recheck ppd
    if negative, repeat in 8 weeks to look for conversion, may be a false negative
  236. positive and negative quantiferon resutls
    • positive: +mitogen, -Nil, + result in EITHER tube 1 or 2. tube 1 or 2 minus nil is >0.35iu/mL
    • negative: + mitogen, -nil, - result in BOTH tubes 1 and 2
    • indeterminate result: - mitogen (immunosuppresed), +nil (high background noise)
  237. quantiferon false negative and false positive meanings
    • false neg: window of new infection. can take 8-12 weeks after new infection to test pos
    • false pos: a different type of mycobacterium infection (not BCG tho)
  238. can tb tests tell you if active vs latent
    no. just infection. dont know if active or not
  239. will igra and ppd be positive even after tb treatment
    • yes. both are positive FOR LIFE. 
    • dont recheck
  240. if you get a positive TB test one way (ppd, igra) should you confirm and get the other test
    no, go straight to CXR and symptom eval
  241. how can you rule out active TB after positive test
    • cxr
    • symptom eval: cough, fever, night sweat, weight loss, cp, lymph node well
    • ask if prior tb treatment
    • trend weight, pulm exam, lymph and abd exam
    • look at risk

    if no positives, its ruled out
  242. what CXR should you do for TB eval
    • PA view adults
    • PA and lateral view kids to look for subtler changes and lymphadenopathy
  243. do you need a negative chest xray before starting latent tb tx? if so, how long ago can it be
    • yes
    • need a negative cxr within 2 mo prior to starting tx
    • bc we want to be really sure they dont have active TB
  244. if a patient already received tx for active or latent tb, do they need it again?
    no, unless they have concerning symptoms- do cxr and get sputum
  245. do you need to report latent TB
    yes, to MA DPH
  246. how urgent is tb treatment
    very urgent: contact with confirmed + case, documented conversion from negative to positive test within 2 years (something has changed), immunosuppression (current or planned), HIV

    remember 2 years after exposure is highest risk for active
  247. Latent TB regimens
    • rifampin 600 mg daily x 4mo
    • isoniazid 300mg daily 6-9 mo
    • isoniazid 900mg + rifapentine 900mg AKA 3HP weekly for 3 months
  248. which latent tb tx is better
    • rifampin: less liklihood for hepatotoxicity, shorter course, however inhibits ocp and turns fluids orange
    • isoniazid: no interaction with ocp, safe in pregnancy, however longer course
    • 3HP: only 3 months, only once a week, less liklihood for liver toxicity, also DOT so low risk of non adherence
  249. if on isoniazid for latent tb, should it be 6 or 9 mo
    6 mo shown to work but NOT approved by Mass DPH, they want 9
  250. rifampin treatment for latent tb
    • 600mg/day for 4 mo
    • good for adults and children with no med interactions who can take daily meds. use in preg ONLY if Isoniazid cant be used. ok for breastfeeding
    • causes orange discoloration body fluids
    • se: rash, flu sx, hepatitis, fever, thrombocytopenia
    • cyp INDUCER- lower drug levels such as ART, hormonoal contraceptives, anticonvulsants, glucocortioicds, coumadin, oral DM meds 

    CONTRAINDICATED IF HIV TREATMENT
  251. isonazid treatment overview
    • 300 mg daily x 9mo
    • fewest drug interactions, but longest regimen
    • ok for adults and kids unable to take rifamycin/3HP
    • preferred for preg, ok for breastfeed
    • se: rash, hepatotoxicity, peripheral neruopathy, CNS effects
    • few drug interactions- phenytoin and disulfiram
    • CHECK LFTS- hepatotoxicity risk.
  252. what should you give with isoniazid
    • pyridoxine (vitamin B6) 25-50mg/day to prevent peripheral neuropathy
    • esp if DM, HIV, kid failure, alcoholism, or preg/breastfeed
  253. at what LFT levels should you stop isoniazid/rifampin/inh
    • 3x the upper limit and symptomatic
    • 5x the upper limit regardless of symptoms
  254. isoniazid-rifapentine  3HP treatment overview
    • 1 dose a week x 12 weeks (900mg iso, 900 rfapentine) 
    • DOT- low chance of nonadherence, but must commit
    • in adults in kids over 2 with no drug interactions
    • not safe for preg, ok for breastfeed
    • se: flu like rxn, hepatotoxicity, peripheral neuropathy, all the other isoniazid and rifampin sx
    • many drug interactions- rifampine has cyp induction
  255. rifampin and cancer
    • excess nitrosamine impurities found in rifampin and rifapentine
    • carcinogenic potential, but risk EXTREMELY low. needs long term exposure
  256. what are the big interactions with rifamycins
    • ocps dont work
    • arts dont work- CONTRAINTICATED IF HIV
  257. should you treat latent tb in pregnancy
    • defer if you can, and same if less than 3mo postpartum
    • UNLESS high risk- confirmed contacted case. 
    • isoniazid
  258. does rifamycins affect all birth control
    • all hormonal yes. 
    • only paraguard or condom use safe
  259. when do you need baseline lft testing if starting latent TB therapy
    • HIV
    • pregnancy
    • liver diseae
    • alcohol/hepatotoxic drug use
    • chemo
    • over 50 years if you think risk
  260. how often do you follow up with people on latent tb treatment
    • monthly
    • check adherence, s/sx adver reactions
    • look for s/sx hepatotoxicity- check LFTs
    • check LFTs perioridically, dont need to follow if no sx
  261. ESR
    • measures how fast RBCs settle to bottom of test tube
    • inflammation and infection have extra proteins that make this happen faster
    • rises as people age- upper limit changes
  262. eitiologies of elevated esr
    • infection
    • malignancy
    • anemia (up to 40-45)
    • age
    • ckd
    • autoimmune
    • obseity
  263. ESR upper limit of normal
    • lab lists at 20, but depends on age
    • males: age/2
    • females: age/2 + 10
  264. crp
    • a protein synthesized by the liver in response to factors released by macrophages and fat cells
    • 2 types: inflammatory and high sensitivity (hs)
  265. types of CRP and meaning
    • inflammatory: used for rheumatic diseaes and inflammation
    • High sensitivity (hs): used for cardiac testing. Not rheumatic disease
  266. eitiologies for elevated inflammatory CRP
    • SMOKING
    • obesity (high IL6 from adipose tissue increases it)
    • dm
    • inactivity
    • hrt
    • htn
    • depression
    • preg
    • malignancy
    • autoimmune
    • infection
  267. CRP upper limit
    • also elevates with age
    • male: age/50 mg/Dl; age/5 mg/L
    • female: age/50+ 0.6 if mg/dL; age/5 + 6 if Mg/L
  268. polymyalgia rheumatica symptoms
    • painful shoulder & hip girdle for 1 mo, worse at night. starts in shoulders then might involve hip girdle
    • swelling in joints, upper arms/neck, hips, butt, groin, thighs. Occasionally wrist, sternoclavicular joint, knee. NO swelling in small joints of hands/feet/ankle
    • pain and stiffness at night. they go to sleep fine but wake up in middle of night due to discomfort takes 45+ min in the AM to get going
    • no objective weakness, may be guarding
    • fever, weight loss mailase
  269. when does PMR usually happen
    • over 50 years, most in the 70s
    • more in women
    • more in caucasion, north climate
  270. gelling phenomenon
    • pt with PMR sits for a while an then they try to get up and are really stiff
    • takes 10 ish mins to loosen up from sitting
    • different from OA where its just a few step
  271. PMR physical exam findings
    • pain with ROM of shoulder an hips, but they look normal
    • they dont want you to abduct the shoulder more than 80 deg
    • normal x ray no fracture. migt see OA, but likely wont be in all affected joints
  272. PMR labs
    • elevated ESR  over 40, often over 100
    • elevated CRP
    • WBC
    • platelets are elevated- means systemic inflammation and autoimmune
    • decreased H&H
  273. is PMR permanent?
    • mostly no, self limiting about 2 years
    • can reoccur in 10% patients, some will have lifelong disease (can try methotrexate)
  274. PMR complications
    • temporal arteritis
    • steroid induced osteoporosis
  275. PMR treatment
    • 20mg prednisone daily
    • they should have a rapid positive response to this
    • methotrexate in those with recurrent disease/lifelong
  276. pmr prednisone schedule
    • start at 20mg daily
    • start at 10-15 if uncontrolled DM
    • make sure no NSAID use or warfarin
    • taper by 2.5 mg daily q2-4 weeks down to 10mg then by 1mg monthly
    • NO BURST
    • if cant taper steroids you can add methotrexate
    • some will need lifelong steroids
  277. PMR presentation acronym
    • SECRET
    • S tiffness and pain
    • E lderly
    • C onstitutional sx (fever, weightloss, malaise), C aucations
    • E levated ESR
    • T emporal arteritis
  278. differentiating PMR from rheumatoid arthritis
    • RA will have rheumatoid facture pos, PMR wont, however, other things like hepatitis can raise it
    • RA will have CCP (cyclic citrullinated peptide), PMR wont. this lab is VERY specific to RA
  279. when treating for PMR with steriods, what else should you give
    • calicum and VIT D
    • 600mg BID calcium0 from diet is best. needs to be BID cant absorb more than 600 at a time
    • vit d 1000 units daily, maybe 2,000-5000 u
    • potentially bisphosphonates for osteoporosis
  280. temporal arteritis
    • temporal artery in front of ear is enlarged and tender
    • EMERGENCY r/t blindness
  281. who gets temporal arteritis
    • high correlation with PMR
    • over 50, 10x more common at age 80 than 50-60
    • females 2x
    • genetic corrlation 
    • whites of norther european
  282. temporal arteritis s/sx
    • insidious onset- PMR comes on quickly, this takes a week or 2
    • headache- temporal or occipital, does not get better with tylenol or NSAID
    • scalp tenderness
    • jaw/tongue claudication- trouble chewing, jaw hurts
    • visual loss- diplopia, in and out, black lightening, shade over eye
    • joint pain- shoulder neck, hip girdle bc tied to PMR
    • fever weight loss mailase- vasculitis of the med and large vessels- a step up and more severe than PMR
    • cant put head on a pillow (may indicate occipital artery involved)
  283. BIGGEST worry with temporal arteritis
    • vision loss
    • often irreverible
  284. temporal arteritis dx
    • need a temporal artery biopsy
    • need a big area bc you can miss it- its intermittent in the arteries
    • send to ED for this
  285. giant cell arteritis physical exam findings
    • scalp tenderness
    • tortuous arteries
    • absent pulses- scalp arteries, brachial, radial, femoral depending on where inflammation is
    • bruit
    • > 10mmHg bp difference in the arms
    • abdominal pain if affected here
  286. what should you give a pt with suspected temporal arteritis before sending to ED
    • 60mg prednisone
    • should have rapid response
  287. Giant cell arteritis complications
    • affects medium and large vessels- including aorta and branches
    • increased aneruism risk, blindness, CVA, MI, Htn
  288. giant cell arteritis labs
    • esr: elevated
    • crp: high
    • ferritin: high
    • platelets: high
  289. what size temporal artery biopsy do you want and what do findings mean
    • 3-6cm
    • bilateral if possible
    • if + they have gca
    • if - either negative or you missed it. slowly taper of steroids but if comes back, start up again and get another biopsy
  290. is giant cell arteritis self limiting
    • usually lifelong
    • at least years to treat
    • after GCA, the artery is scarred, it doesnt go back to normal
  291. what imaging can you get if you suspect giant cell arteritis
    • ultrasound: look for halo sign
    • if they have abdominal signs- MRA, PET, CTA
  292. prednisone for giant cell arteritis
    • start at 60mg daily and immediate biopsy
    • after 1 mo taper to 55 for 2 weeks then 50 for 2 weeks etc
    • all on steroids for 2 years, 40% will need for life
    • if visual changes 1mg/kg IV methylprednisolone x 3 days
  293. what other meds for giant cell arteritis besides steroids
    • bactrim: prophylaxis against pneumocystitis bc high risk infection when on steroids
    • Aspirin 81 mg daily: prevent blindness and ASCVD
    • methotrexate: used as steroid sparing
    • tocilizumab: may allow pts to stop steroids. an il-6 inhibitor. stops gca associated inflammation. sub q or IV for severe. will make CRP normal always, do sed rate, even tho this normalizes a bit too
  294. is prednisone or methylprednisolone better
    • methylprednisolone
    • prednisone goes through liver TWICE, methoprednysolone only once
    • more side effects with prednisone- so avoid in those with psych issues
    • methylprednisolone is 25% stronger than prednisone, lesser doses do more
  295. complications with giant cell arteritis treatment
    • steroid stuff
    • osteoporosis- may need bisphosphonates
    • dm
    • mood disorders
    • weight gain
    • cataracts, glaucoma
    • HTN
    • infections- double dose on sick days
  296. Systemic lupus erythematous pathophys
    • chronic autoimmune diseae where autoantibodies and complemetn deposit in the tissues leading to inflammation
    • where the deposition occurs determines the s/sx. ie skin lesions, renal failure, cva, pulm lsions
  297. 5 types of lupus
    • sle
    • lupus profundus
    • lupus timidis
    • subacute lupus
    • lupus dermoidis
  298. can someone with a derm lupus get SLE
    • YES, 5-7%
    • but the closer you come to a decade of having derm lupus, the less likely you will get SLE
  299. who gets lupus
    • women childbearing age 15-45
    • 14x higher in klinefelters (xxy)- something x linked
    • 3-4x more common in black, asian, hispanic 
    • 8:1 females to male
  300. lupus risk factors
    • SMOKING
    • virus (ebv, cmv, silca exposure)
    • pesticides
    • demethylating cancer drugs
    • genetics - fam hx autoimmune probs
    • histocompatability complex DR2 and DR3
    • C1q, C2 C4 deficiencies
  301. ANA and lupus
    • antinuclear antibody
    • NOT SPECIFIC FOR LUPUS. only 5% of those with + ANA actually have sle
    • do not order for joint pain or fatigue- need other sx like reynaudes, pleurisy, pericarditis, or cytopenias
  302. positive ANA
    • 1:160 or more
    • only order if they have connective tissue symptoms: reynaud, pleurisy, lymphopenia, anemia, thrombocytopenia, alopecia, photosensitive rashes. not just for fatigue/joint pain. its not specific
    • centromere pattern is specific for CREST syndrome
  303. crest syndrome
    • calcinousis 
    • reynauds
    • esophagyl dysmotility
    • sclerodactylity 
    • talangiectasias
  304. Lupus labs
    • double stranded DNA
    • anti-smith antibody
    • ribosomal P protein- highly specific for SLE when elevated
    • complement- total hemolytic complement- ch50, c3 and C4 will be low
    • anti-histones in drug induced lupus (procainamide, minocycline, hydralazine, INH, methyldopa, TNF)
  305. what do you give if they have drug induced lupus and have been just taken off the offending agent but not getting better
    • check anti histones- elevateed
    • hydroxychloroquine or prednisone may be required until theyve been off the offending agent for months
  306. lupus manifestations
    • complex, depends on system
    • general: fever, fatigue, weight loss
  307. lupus ESR and CRP
    • not elevated, only elevate if infection
    • can be used if they have a fever to rule out infection
    • fever can be lupus or infection
  308. what is a scary complicaiton of lupus
    • renal
    • end stage renal disease more likely in black, hispanic, males poor med compliance, htn, dm, failure to normalized Cr or still proteinuria after 6mo treatment
  309. lupus when to get a renal biopsy
    • proteinuria more than 1g in 24 hours OR
    • Proteinuria more than 0.5g in 24 hours PLUS hematuria or cellular casts
  310. renal involvement in lupus
    • avoid nsaids- dont want to raise bp and decrease nephron perfusion more
    • stop smoking
    • control BP
    • many pts die from renal or cv complications
    • get a urine q3 mo on all lupus pts and refer to nephrology
  311. hematologic manifestations of lupus
    • autoimmune hemolytic anemia: cbc- spherocytes, haptoglobin; bilirubin, lactate dehydrogenase, reticulocyte count, direct coombs
    • lymphopenia, neutropenia: exclude med cause first (ie celsat)
    • thrombocytopenia: dont treat unles PLT under 30 or having bleeding
    • antiphospholipid antibody syndrome: beta 2 glycoproteins and anticardiolipans should be tested. if high, repeat in 3mo, if high again, this is your dx
    • anemia of chronic disease
    • thrombotic thrombocytopenic purpura: schistocytes on CBC, high LDH
    • macrophage activation syndrome (MAS): fever, cytopenias, organ dysfunction, splenomegaly, low ESR
    • Elevated triglycerides
  312. antiphospholipid antibody syndrome
    • a manifestation of lupus sometimes
    • aka lupus anticoagulant syndrome
    • doesnt always mean they have lupus if they have this
    • increases risk of clotting
    • test beta 2 glycoproteins, anticardiolipans- if high, repeat in 3 mo, if high again, DX it
    • increases risk of preg loss- loosing many pregs? think this maybe
    • anticoagulation, not aspirin can prevent clotting event
  313. lupus articular joint manifestations
    • nonerosiver arthritis
    • swan neck deformities
    • ulnar deviation
    • lupus and steroid use lead to avascular necrosis- often bilateral- shoulders and hips
    • laxity in joint capsule and laxity of extensor tendon causes deformity
  314. Rhupus
    • erosive systemic arthritis with + RF and cyclic citrullinated peptide antibody
    • rare
    • positive rheumatoid factor and ccp
    • the artrhitis here is erosive and damages bone
    • symmetrical
  315. dermatological lupus manifestations
    • butterfly malar rash
    • hand rash BETWEEN, not over joints
    • stomatitis on upper palate, tongue, or cheeks/lips
    • alopecia
  316. discoid lupus
    • very well circumscribed slightly raised boarder with dry skin or scale in middle
    • does not bleed if picked like psoriasis does
    • get a biopsy, send to derm
  317. subacute lupus
    • ringworm like rash, no central scab
    • well circumscribed boarders but with central clearing
  318. caridovascular manifestations of lupus
    • pericarditis
    • myocarditis
    • vasculitis
    • reynauds
    • mi
    • cad
    • htn
    • valvular disease
    • antiphospholipid antibody syndrome
  319. reynauds
    • color of hand changes white with temp change to cold
    • absence of blood to the extremity
    • usuallystarts in one finger from tip to DIP joint then over time will develop in other fingers
    • when colder temp, triggers system to clamp arteries so no blood
    • they rewarm and things might turn blue then red and is painful
  320. reynauds tx
    • mittens
    • heated steering wheel
    • calcium channel blockers
    • dress as if its 20 degrees colder than it is
  321. what is reynauds seen with
    • lupus, systemic scleroderma, mixed connective tissue disease, CREST syndrome
    • not really seen with RA
  322. reynauds dx
    • modified allens test
    • clench their fists 5x see if blood returns
  323. lupus pulmonary manifestations
    • pleuritis
    • pneumonitis with and without hemorrhage
    • interstitial lung disease
    • pulmonary fibrosis
    • pe
    • can affect anywhere on the lung
  324. lupus neruological manifestations
    • cva
    • seizure
    • psychosis and psych problems
    • memory issues
  325. Systemic lupus erythematous treatment
    • prednisone
    • hydroxychloriquine- for EVERY PT
    • cyclophosphomide- for nephritis. causes infertility and bladder CA- low doses
    • mycophenolate mofetil (cellcept)- antiimmune
    • azothioprine, cyclosporine, tacrolimus- antiimmune
    • benylsta
    • rituximab
    • ACE/ARB for kidney protection
    • statins for ascvd
    • smoking cessatino
  326. can lupus become pregnant
    • yes but HIGH risk
    • we need to know if theyre planning this, some drugs ie cellcept not safe
Author
iloveyoux143
ID
357925
Card Set
761 Exam 3
Description
Updated